Drug testing plays a critical role in monitoring patients who are prescribed controlled substances, have substance use disorder (SUD) or are exposed to drugs unintentionally. Labcorp has developed comprehensive testing services to meet your drug testing needs for your patients.
Our clinical drug testing compendium includes various methodologies, drug classes/metabolites, detection thresholds and interpretive reports designed for your clinical needs.
Labcorp's clinical drug testing helps you make deliberate decisions so you can focus on the care for each individual patient. Across our capabilities, you have the flexibility to choose tests and profiles along with the convenience of ordering test combinations and profiles. Together we can enhance patient care.
Our test options are specifically designed to monitor a diverse range of patient types and medication use. This includes patients undergoing chronic opioid therapy or chronic therapy involving other controlled substances.
Support the comprehensive care of patients with opioid use disorder (OUD), our Medication-Assisted Treatment (MAT) drug testing portfolio offers a range of testing options tailored to their needs.
Offering a comprehensive and contemporary menu of tests for novel psychoactive substances, our selection ensures screening and detection capabilities to address evolving challenges in substance use monitoring and patient care.
YOUR PARTNER IN CLINICAL DRUG TESTING
General drug testing may be useful when screening for unexpected drug use. This may include, but is not limited to, evaluating underlying causes of medical conditions or behaviors, or screening patients prior to certain treatments. These tests are not designed to monitor compliance with prescribed medications or medication-assisted treatment of opioid use disorder.
Labcorp offers direct access to our team of experts to support you and provide technical or medical consultation.
For test menu inquiries, add-on or test change requests, and results status.
For results interpretation and technical discussion of patient-specific drug test results.
